Resmonics’ mission is to develop disease self-management solutions for chronic respiratory diseases that are truly compatible with patients’ everyday lives. By offering our solutions to other companies for integration into their already existing products, we empower them to deliver a completely new and highly attractive value proposition to their end users (patients). Our first product, Asthma Guardian, turns a patient’s smartphone into a guardian angel at night that protects them from life-threatening disease escalations (such as asthma attacks). The technology behind Asthma Guardian, namely deep learning based digital biomarkers, has been developed and clinically validated in five years of research at leading Swiss universities and healthcare providers.